Physician profile
Wayne B Cestia
NPI 1811105513
$1,139.30
in general payments reported to CMS, 2019-2025
10 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $155 · 2021: $116 · 2022: $105 · 2023: $183 · 2024: $47.27 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Entertainment: $13.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.00 |
| Entertainment | $13.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $541.24 | 2019-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $386.25 | 2019-2023 | |
| Lilly USA, LLC | $60.39 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $44.09 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $27.80 | 2025 | |
| Sanofi Pasteur INC. | $22.64 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $15.60 | 2025 | Gardasil 9 |
| Astellas Pharma US INC | $13.90 | 2023 | Veozah |
| Optos, INC. | $13.84 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Neos Therapeutics, LP | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Cestia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.